Table 2.

Recommendations where strength of agreement was agree (median ≥7) but variation in extent of agreement was high (MADM score >1.75)

	Recommendation	Median	Mean absolute deviation from the median (MADM)
22	All teams should have a designated person at each MDT meeting to help identify suitable patients for clinical trials	7	1.88
23	Patients should be given feedback on all treatment options, even those rejected by the MDT	7	2.25
24	Patients should be able to choose the mode of MDT meeting feedback (e.g. written, phone call, in clinic)	7.5	2.19